FDA approval of new drug
2026 · 2nd Quarter (Apr 1 - June 30)
ADNEURIS THERAPEUTICS, INC.
Filed by MAD GLOBAL STRATEGY.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jun 24, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- MAD GLOBAL STRATEGY
- Filing UUID
- 1352a17a-25b4-4497-b433-dbf0438ccdf0
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FDA approval of new drug
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.